IL23 secreted by myeloid cells drives castration resistant prostate cancer

Prostate cancer patients frequently experience resistance to androgen deprivation therapy (ADT). Acquiring a better understanding of the mechanisms controlling the development of castration resistant prostate cancer (CRPC) remains an unmet clinical need. The well-established dependency of cancer cel...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Nature
Autores principales: Calcinotto, Arianna, Spataro, Clarissa, Zagato, Elena, Di Mitri, Diletta, Gil, Veronica, Crespo, Mateus, De Bernardis, Gaston, Losa, Marco, Mirenda, Michela, Pasquini, Emiliano, Rinaldi, Andrea, Sumanasuriya, Semini, Lambros, Maryou B., Neeb, Antje, Lucianò, Roberta, Bravi, Carlo A., Nava-Rodrigues, Daniel, Dolling, David, Prayer-Galetti, Tommaso, Ferreira, Ana, Briganti, Alberto, Esposito, Antonio, Barry, Simon, Yuan, Wei, Sharp, Adam, de Bono, Johann, Alimonti, Andrea
Formato: Artigo
Lenguaje:Inglês
Publicado: 2018
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6461206/
https://ncbi.nlm.nih.gov/pubmed/29950727
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41586-018-0266-0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares